Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · Real-Time Price · USD
12.22
-0.99 (-7.53%)
At close: Mar 18, 2026, 4:00 PM EDT
12.10
-0.12 (-0.98%)
After-hours: Mar 18, 2026, 4:10 PM EDT

Contineum Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2022
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
75.621.9415.535.574.63
Short-Term Investments
187.29182.82109.6641.6764.37
Cash & Short-Term Investments
262.9204.76125.1947.2469
Cash Growth
28.39%63.56%165.01%-31.54%-
Other Current Assets
5.021.632.521.150.78
Total Current Assets
267.92206.39127.7148.3969.78
Net Property, Plant & Equipment
8.476.461.42.120.64
Other Long-Term Assets
0.2601.280.130.1
Total Assets
276.64212.85130.3950.6470.52
Accounts Payable
1.021.810.640.430.66
Accrued Expenses
6.396.714.392.061.76
Current Portion of Long-Term Debt
---3.951.25
Current Portion of Leases
2.341.450.461.11-
Total Current Liabilities
9.749.975.487.553.67
Long-Term Debt
----3.66
Long-Term Leases
5.914.810.110.79-
Other Long-Term Liabilities
--0.113.031.6
Total Long-Term Liabilities
5.914.810.223.825.26
Total Liabilities
15.6514.785.711.378.93
Common Stock
0.040.03000.01
Additional Paid-in Capital
438.07315.377.14.732.74
Accumulated Other Comprehensive Income
0.260.070.11-0.08-0.04
Retained Earnings
-177.38-117.4-75.14-97.86-73.61
Total Common Shareholders' Equity
260.99198.07-67.94-93.21-70.89
Minority Interest
--192.62132.48132.48
Shareholders' Equity
260.99198.07124.6839.2761.59
Total Liabilities & Equity
276.64212.85130.3950.6470.52
Total Debt
8.256.260.575.854.91
Net Cash (Debt)
254.65198.5124.6241.3964.1
Net Cash Growth
28.28%59.29%201.08%-35.42%-
Net Cash Per Share
9.1910.2636.7018.45-
Book Value
260.99198.07-67.94-93.21-70.89
Book Value Per Share
9.4210.23-20.01-41.56-
Tangible Book Value
260.99198.07-67.94-93.21-70.89
Tangible Book Value Per Share
9.4210.23-20.01-41.56-
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q